Publications by authors named "C Panizo"

Claim this Profile
S
SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor.
Ricardo García-Muñoz, Jone Alberdi-Ballina, Giovanna Farfan-Quiroga, Eloy F Robles, María José Larráyoz, Carlos Panizo

Blood Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.
Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, Camila Guerrero, Anastasiia Zherniakova, Aintzane Zabaleta, Carlos Panizo

Blood Cancer J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study.
Pau Abrisqueta, Eva González-Barca, Carlos Panizo, José María Arguiñano Pérez, Fiona Miall

Lancet Haematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Steven Le Gouill, Monika Długosz-Danecka, Simon Rule, Pier Luigi Zinzani, Andre Goy, Carlos Panizo

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia, María José Rodríguez-Salazar, Ana Jiménez-Ubieto, Carlos Panizo

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis